Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis

Por Stellbrink, Hans-Juergen, Antinori, Andrea, Pozniak, Anton, Flamm, Jason, Bredeek, Fritz, Patel, Kiran, Garner, Will, Piontkowsky, David
Publicado no J Int AIDS Soc (2014)

144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort

Por Wolf, Eva, Trein, Andreas, Baumgarten, Axel, Stephan, Christoph, Jaeger, Hans, Hillenbrand, Heribert, Koeppe, Siegfried, Lutz, Thomas, Koenig, Bettina, Stellbrink, Hans-Juergen
Publicado no J Int AIDS Soc (2014)

MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

Por Meier, Angela, Alter, Galit, Frahm, Nicole, Sidhu, Harlyn, Li, Bin, Bagchi, Aranya, Teigen, Nickolas, Streeck, Hendrik, Stellbrink, Hans-Juergen, Hellman, Judith, van Lunzen, Jan, Altfeld, Marcus
Publicado em 2007

Expansion of pre-existing, lymph node-localized CD8(+) T cells during supervised treatment interruptions in chronic HIV-1 infection

Por Altfeld, Marcus, van Lunzen, Jan, Frahm, Nicole, Yu, Xu G., Schneider, Claus, Eldridge, Robert L., Feeney, Margaret E., Meyer-Olson, Dirk, Stellbrink, Hans-Juergen, Walker, Bruce D.
Publicado em 2002

Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1–Infected Individuals before and after Effective Therapy

Por Zhang, Linqi, Lewin, Sharon R., Markowitz, Martin, Lin, Hsi-Hsun, Skulsky, Eva, Karanicolas, Rose, He, Yuxian, Jin, Xia, Tuttleton, Sarah, Vesanen, Mika, Spiegel, Hans, Kost, Rhonda, van Lunzen, Jan, Stellbrink, Hans-Juergen, Wolinsky, Steven, Borkowsky, William, Palumbo, Paul, Kostrikis, Leondios G., Ho, David D.
Publicado em 1999